JP2013173796A5 - - Google Patents

Download PDF

Info

Publication number
JP2013173796A5
JP2013173796A5 JP2013117401A JP2013117401A JP2013173796A5 JP 2013173796 A5 JP2013173796 A5 JP 2013173796A5 JP 2013117401 A JP2013117401 A JP 2013117401A JP 2013117401 A JP2013117401 A JP 2013117401A JP 2013173796 A5 JP2013173796 A5 JP 2013173796A5
Authority
JP
Japan
Prior art keywords
chronic skin
connexin
polynucleotide
pluronic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013117401A
Other languages
English (en)
Japanese (ja)
Other versions
JP5911454B2 (ja
JP2013173796A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013173796A publication Critical patent/JP2013173796A/ja
Publication of JP2013173796A5 publication Critical patent/JP2013173796A5/ja
Application granted granted Critical
Publication of JP5911454B2 publication Critical patent/JP5911454B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013117401A 2006-12-11 2013-06-03 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド Expired - Fee Related JP5911454B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87440406P 2006-12-11 2006-12-11
US60/874,404 2006-12-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009541370A Division JP5431949B2 (ja) 2006-12-11 2007-12-11 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015000248A Division JP2015063565A (ja) 2006-12-11 2015-01-05 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Publications (3)

Publication Number Publication Date
JP2013173796A JP2013173796A (ja) 2013-09-05
JP2013173796A5 true JP2013173796A5 (https=) 2014-04-10
JP5911454B2 JP5911454B2 (ja) 2016-04-27

Family

ID=39386432

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009541370A Expired - Fee Related JP5431949B2 (ja) 2006-12-11 2007-12-11 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド
JP2013117401A Expired - Fee Related JP5911454B2 (ja) 2006-12-11 2013-06-03 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド
JP2015000248A Pending JP2015063565A (ja) 2006-12-11 2015-01-05 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009541370A Expired - Fee Related JP5431949B2 (ja) 2006-12-11 2007-12-11 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015000248A Pending JP2015063565A (ja) 2006-12-11 2015-01-05 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Country Status (15)

Country Link
US (5) US8063023B2 (https=)
EP (3) EP2101791B1 (https=)
JP (3) JP5431949B2 (https=)
KR (1) KR101521306B1 (https=)
CN (2) CN101835476B (https=)
AU (1) AU2007333535B2 (https=)
BR (1) BRPI0721094A2 (https=)
CA (1) CA2672220A1 (https=)
DK (1) DK2101791T3 (https=)
ES (1) ES2527131T3 (https=)
PL (1) PL2101791T3 (https=)
PT (1) PT2101791E (https=)
RU (1) RU2521329C2 (https=)
SI (1) SI2101791T1 (https=)
WO (1) WO2008073479A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1959981T3 (da) 2005-02-03 2020-01-27 Coda Therapeutics Ltd Anti-connexin 43 forbindelser til behandling af kroniske sår
EP2091557A2 (en) 2006-11-15 2009-08-26 Coda Therapeutics, INC. Improved methods and compositions for wound healing
CN101835476B (zh) 2006-12-11 2016-08-17 科达治疗公司 作为受损伤口愈合组合物的抗连接蛋白多核苷酸
US20080249044A1 (en) * 2007-04-03 2008-10-09 Masaya Tanaka Nucleic acid external skin formulation
EP2245158A2 (en) * 2007-12-11 2010-11-03 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
US20110300130A1 (en) * 2007-12-11 2011-12-08 Becker David L Impaired wound healing compositions and treatments
JP2011507861A (ja) * 2007-12-21 2011-03-10 コーダ セラピューティクス， インコーポレイテッド 線維症性の状態の治療のための抗コネキシンポリヌクレオチド剤と組み合わせた抗コネキシンポリペプチド剤の使用
US8975237B2 (en) 2007-12-21 2015-03-10 Coda Therapeutics, Inc. Treatment of fibrotic conditions
WO2012076985A2 (en) * 2010-12-06 2012-06-14 The University Of British Columbia Granzyme b inhibitor compositions, methods and uses for promoting wound healing
GB201117538D0 (en) * 2011-10-11 2011-11-23 Royal Veterinary College The Methods
CA2866115C (en) 2012-03-01 2020-03-24 Firststring Research, Inc. Topical gels containing alpha connexin c-terminal (act) peptides
CA2868534A1 (en) * 2012-03-27 2013-10-03 Coda Therapeutics, Inc. Compositions and treatments based on cadherin modulation
US9156896B2 (en) * 2013-03-15 2015-10-13 Coda Therapeutics, Inc. Wound healing compositions and treatments
WO2015139047A2 (en) * 2014-03-14 2015-09-17 Coda Therapeutics Treatment of resistant lesions
US10465188B2 (en) 2014-08-22 2019-11-05 Auckland Uniservices Limited Channel modulators
EP3334436A4 (en) * 2015-08-13 2019-05-29 SomaGenics Inc. PROCESSES AND COMPOSITIONS OF SHORT-SMALL-HAIRPIN-RNAS AND MICRO-RNAS FOR WOUND HEALING
WO2018060144A1 (en) * 2016-09-27 2018-04-05 Smith & Nephew Plc Wound closure devices with dissolvable portions
CN111201247A (zh) 2017-04-28 2020-05-26 奥克兰联合服务有限公司 治疗方法和新颖构建体
CN108588075A (zh) * 2018-05-03 2018-09-28 天德悦（北京）生物科技有限责任公司 人Cx43基因干扰序列、shRNA-Cx43病毒及低表达Cx43蛋白的细胞系
JP2023546757A (ja) 2020-10-22 2023-11-07 シークエル・バイオ・インコーポレイテッド ペプチド製剤および眼科におけるその使用
RU2754383C1 (ru) * 2020-12-07 2021-09-01 Федеральное Государственное Бюджетное Учреждение "Национальный Медицинский Исследовательский Центр Эндокринологии" Министерства Здравоохранения Российской Федерации (Фгбу "Нмиц Эндокринологии" Минздрава России) Способ лечения неинфицированного послеоперационного раневого дефекта стопы при отсутствии признаков критической ишемии конечности у больных с нейропатической и нейроишемической формой синдрома диабетической стопы

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0539594Y2 (https=) * 1988-08-05 1993-10-07
US5004810A (en) 1988-09-30 1991-04-02 Schering Corporation Antiviral oligomers
US5166195A (en) 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
GB9425930D0 (en) 1994-12-22 1995-02-22 Procter & Gamble Silicone compositions
JP2001505432A (ja) 1996-12-02 2001-04-24 ダイヤド ファーマシューティカル コーポレイション ヒト接着分子のアンチセンス阻害
RU2147240C1 (ru) * 1998-02-16 2000-04-10 Рязанский областной клинический кожно-венерологический диспансер Препарат для лечения длительно незаживающих инфицированных язв и ран
DK1146908T3 (da) * 1999-01-27 2005-10-10 Becker David Dr Formuleringer omfattende antisense-nukleotider mod connexiner
US7250397B2 (en) 2000-02-23 2007-07-31 Zealand Pharma A/S Antiarrhythmic peptides
US20050119211A1 (en) * 2001-05-18 2005-06-02 Sirna Therapeutics, Inc. RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
WO2003032964A2 (en) 2001-10-17 2003-04-24 University Of Wales College Of Medecine Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
HRP20040784A2 (en) * 2002-01-29 2005-04-30 Wyeth Compositions and methods for modulating connexin hemichannels
CA3059497A1 (en) * 2003-12-03 2005-06-16 Ocunexus Therapeutics, Inc. Antisense compounds targeted to connexins and methods of use thereof
DE102004027422A1 (de) 2004-06-04 2005-12-29 Boehringer Ingelheim Microparts Gmbh Vorrichtung zur Aufnahme von Blut und Abtrennung von Blutbestandteilen
SG158153A1 (en) 2004-12-21 2010-01-29 Musc Found For Res Dev Compositions and methods for promoting wound healing and tissue regeneration
DK1959981T3 (da) 2005-02-03 2020-01-27 Coda Therapeutics Ltd Anti-connexin 43 forbindelser til behandling af kroniske sår
EP2091557A2 (en) 2006-11-15 2009-08-26 Coda Therapeutics, INC. Improved methods and compositions for wound healing
CN101835476B (zh) 2006-12-11 2016-08-17 科达治疗公司 作为受损伤口愈合组合物的抗连接蛋白多核苷酸
CN101765423B (zh) 2007-05-31 2014-08-06 安特里奥公司 核酸纳米粒子和其用途
EP2245158A2 (en) 2007-12-11 2010-11-03 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
US20110300130A1 (en) 2007-12-11 2011-12-08 Becker David L Impaired wound healing compositions and treatments

Similar Documents

Publication Publication Date Title
JP2013173796A5 (https=)
JP2012041342A5 (https=)
JP2020530857A5 (https=)
EA201490377A1 (ru) Лечение рассеянного склероза комбинацией лаквинимода и глатирамера ацетата
JP2013155188A5 (https=)
JP2015537000A5 (https=)
MD4369B1 (ro) Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei
BR112015010703A2 (pt) composição farmacêutica formulada para administração; método de tratamento ou prevenção de uma doença ou condição susceptível a tratamento com um tocotrienol; método de estabilização e/ou controle de glicemia em um animal; método de minimização da dosagem exigida para atingir um efeito terapêutico pela administração de um tocotrienol em um animal; método de minimização da dosagem exigida para atingir um efeito terapêutico pela administração de um tocotrienol em um animal; método de aperfeiçoamento de resistência ao exercício em um animal; método de aperfeiçoamento da capacidade de exercício em um animal; e uso
JP2015516419A5 (https=)
ME02405B (me) Spojevi pirazola као inhibitori sglt1
RU2014112324A (ru) Применение органического соединения для лечения синдрома нунан
JP2012525358A5 (https=)
RU2011148355A (ru) Применение аллопуринола для ладонно-родошвенного синдрома
JP2012041314A5 (https=)
AR101227A1 (es) Combinaciones de un derivado de n-tiazolil-4-fenoxibencenosulfonamida y un agente farmacéuticamente activo seleccionado a partir de gabapentina y pregabalina para tratar dolor
TN2016000179A1 (en) Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor.
RU2014102494A (ru) Ретиноидные композиции местного применения и способы лечения состояний кожи
JP2013523789A5 (https=)
Bogachev et al. Bioflavonoids and their significance in angiology: focus on diosmin
EA201590936A1 (ru) Композиция левоноргестрела для оптимальной пероральной контрацепции с определенным содержанием левоноргестрела, режим дозирования и фармацевтический препарат
RU2014148062A (ru) Инъекционная фармацевтическая композиция декскетопрофена и трамадола
RU2013148539A (ru) Алиспоривир для лечения инфекции вируса гепатита с
RU2012114097A (ru) Терапевтический агент против хронической боли
EA201592261A1 (ru) Фармацевтические композиции, включающие агомелатин в форме сокристаллов агомелатина с органической кислотой
CN106860602A (zh) 一种用于糖尿病人的药酒